- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common types of lymphoma, accounting for 31% of all non-Hodgkin’s diagnoses. Approximately 79% of cases are B-cell cancers, 16% are T-cell cancers, and the remaining 5% come from an unidentifiable origin. These diseases often affect the elderly population, but they can also affect children.
Large Cell Lymphomas are grouped and classified together because of similarities in the cell mutations and markers. They also present with the same types of symptoms such as fatigue, weakness, weight loss, night sweats, and swollen lymph nodes.
Since these cancers are typically aggressive, they can spread to many different areas in the body. Tumors may develop either in the lymph nodes or other lymph tissue and then spread to the bone, central nervous system, liver, lungs, spleen, testes, thyroid, or gastrointestinal tract.
Diagnosis and staging differs slightly for each subtype of LCL. However, blood work, bone marrow biopsies, X-rays, CT scans, PET scans, and ultrasounds may be used for diagnosis and staging in all cases. Staging depends on the location and spread of the disease, with the lower stages typically contained in one area of the lymph nodes and the later stages marked by spread throughout the body.